🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
LYR
$LYRA
🔒 US EquitiesLyra Therapeutics Inc
AVG HISTORICAL GAP
+0.18%
MAX GAP RECORD
-13.04%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $LYRA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$LYRA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Jun 17, 2026 Earnings Release 2026-06-17 (AFTER CLOSE) |
-13.04%
|
| Nov 12, 2025 Earnings Release 2025-11-12 (AFTER CLOSE) |
+0.00%
|
| Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE) |
+1.78%
|
| May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE) |
+7.35%
|
| Mar 13, 2025 Earnings Release 2025-03-13 (AFTER CLOSE) |
-2.57%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE) |
-3.64%
|
| Aug 14, 2024 Earnings Release 2024-08-14 (AFTER CLOSE) |
+0.52%
|
| Mar 21, 2024 Earnings Release 2024-03-21 (AFTER CLOSE) |
+10.54%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
4.5%
Bullish Gaps (4)
Bearish Gaps (4)
Neutral / Flat (2)
📖 Intelligence Summary
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat (ENT) diseases. The firm's proprietary XTreo platform delivers medicines directly to targeted sites. The company was founded by Carmichael S. Roberts, George M….
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗